'Powerful' new RSV prevention drug should be available to all infants this fall, CDC says

Every newborn and infant under 8 months old should be given a"powerful" new drug to protect them from respiratory syncytial virus this upcoming season, the Centers for Disease Control and Prevention recommended Thursday .

Each year, roughly 1% to 3% of U.S. children the age of 1 are hospitalized due to RSV, the Food and Drug Administration noted in its approval of Beyfortus. Babies born prematurely, those with chronic lung disease and those with significant congenital heart diseases face the highest risk.Related: New RSV vaccine given in pregnancy protects newborns from illness, Pfizer says

The existing drug Synagis is also a lab-made antibody treatment, but Beyfortus requires only a single injection, instead of multiple.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC to meet on FDA-approved RSV vaccine, local mother details twins' health scare last fallRSV is the leading cause of hospitalization in infants under a year old in the United States every year.
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Source: AKNewsNow - 🏆 460. / 53 Read more »

CDC advisers vote to recommend new preventive RSV shot for all infants | CNNAll infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, or RSV, according to a panel of independent experts that advises the United States Centers for Disease Control and Prevention on its immunization recommendations.
Source: CNN - 🏆 4. / 95 Read more »